Secondary prevention of small subcortical strokes (SPS3) trial.
Phase of Trial: Phase III
Latest Information Update: 17 Feb 2016
At a glance
- Drugs Clopidogrel (Primary) ; Aspirin
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms SPS3
- 17 Feb 2016 Results (Levels of Inflammatory Markers in the Treatment of Stroke (LIMITS) study) published in the Stroke (n = 1244).
- 13 Jan 2016 Results of post hoc analysis published in the Circulation
- 02 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History